MaaT Pharma SA (EPA:MAAT)
4.240
-0.070 (-1.62%)
Oct 17, 2025, 5:35 PM CET
MaaT Pharma Revenue
MaaT Pharma had revenue of 2.43 million EUR in the half year ending June 30, 2025, with 76.12% growth. This brings the company's revenue in the last twelve months to 3.92 million, up 52.55% year-over-year. In the year 2024, MaaT Pharma had annual revenue of 3.22 million with 44.34% growth.
Revenue (ttm)
3.92M
Revenue Growth
+52.55%
P/S Ratio
17.41
Revenue / Employee
60.34K
Employees
67
Market Cap
68.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.22M | 988.00K | 44.34% |
Dec 31, 2023 | 2.23M | 798.00K | 55.80% |
Dec 31, 2022 | 1.43M | 458.00K | 47.12% |
Dec 31, 2021 | 972.00K | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 45.74B |
EssilorLuxottica Société anonyme | 27.24B |
Eurofins Scientific SE | 7.14B |
emeis Société anonyme | 5.77B |
Clariane SE | 5.31B |
bioMérieux | 4.12B |
Ipsen | 3.76B |
Sartorius Stedim Biotech | 2.90B |